ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666767 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666767; 2) Community: the network communities that were significantly associated with the response to NSC 666767; 3) Molecule: the relationships between components within communities and NSC 666767; 4) MDR: the compounds that were significantly associated with the NSC 666767.

NSC Compound Enrichment Correlation
NSC 712734 Null 0.0385067071027345 0.062939107
NSC 713198 Benzo[g]quinoxaline-2,5,10(1H)-trione, 5,10-dihydro-3-[[(4-nitrophenyl)hydrazono]methyl]- 0.0385067071027345 -0.22336909
NSC 716344 Null 0.0385067071027345 0.61197429
NSC 716765 Null 0.0385067071027345 0.34761211
NSC 716768 Null 0.0385067071027345 0.18987784
NSC 726262 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one 0.0385067071027345 0.41896175
NSC 735540 5-fluoro-N-(2-methyl-3-oxo-8-phenyl-1-thia-4-azaspiro[4.5]de c-4-yl)-3-phenyl-1H-indole-2-carboxamide 0.0385067071027345 0.41539279
NSC 749292 3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine 0.0385067071027345 0.58944298
NSC 96996 B 169 0.0385067071027345 0.45063446
NSC 163062 TRIPTOLIDE 0.0385203205529756 0.25804659
Total:83  Current:64    [First] [Prev] [Next] [Last]